Ritalin May Help In Treating Addiction
A single dose of Ritalin (methylphenidate) may help improve brain function in people addicted to cocaine, an imaging study carried out by scientists from the Icahn School of Medicine at Mount Sinai showed. The study has been published in JAMA Psychiatry. Ritalin was found to modify connectivity in some of the brain circuits associated with craving and self-control among individuals addicted to cocaine. Previous studies had demonstrated how oral methylphenidate could help cocaine users in resolving a cognitive conflict or ignoring emotionally distracting words... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 29, 2013 Category: Consumer Health News Tags: Alcohol / Addiction / Illegal Drugs Source Type: news
Highland Therapeutics reports positive results from Phase I study of HLD-200
Canada-based Highland Therapeutics has reported positive results from a Phase I study of a novel formulation of methylphenidate, HLD-200, to treat attention-deficit/hyperactivity disorder (ADHD). (Source: Drug Development Technology)
Source: Drug Development Technology - June 26, 2013 Category: Pharmaceuticals Source Type: news
Suicide related events and attention deficit hyperactivity disorder treatments in children and adolescents: a meta-analysis of atomoxetine and methylphenidate comparator clinical trials - Bushe CJ, Savill NC.
BACKGROUND: Attention Deficit Hyperactivity Disorder (ADHD) is becoming an increasingly commonly diagnosed and treated childhood illness. Untreated ADHD is recognised as an independent risk factor for suicide-related events and deliberate self-harm and is ... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - June 26, 2013 Category: Global & Universal Tags: Age: Adolescents Source Type: news
The future of robotics: in a transhuman world, the disabled will be the ones without prosthetic limbs
Bertolt Meyer's amazing bionic hand controlled by an iPhone app is a glimpse of the advances being made in prosthetics. But in years to come, will everyone want one?Bertolt Meyer is used to being viewed as not fully human. Born with a stump where his left hand should have been, he spent his childhood wearing a hook connected to an elaborate pulley and harness. "To open the hook and grasp things I had to flex my shoulders like this," he says, striking a he-man pose. "The harness was very uncomfortable. To stop it chafing my skin, I had to wear a shirt underneath it at all times. I was always sweating."Even when, at the age ...
Source: Guardian Unlimited Science - June 15, 2013 Category: Science Authors: Mark Honigsbaum Tags: Robots Sport Disability sport Society FutureFest Drugs in sport Technology Editorial The Observer Science Source Type: news
Lisdexamfetamine Dimesylate Demonstrates Significantly Faster Response, Greater Reductions Of Core ADHD Symptoms Than Atomoxetine In Study
Shire plc (LSE: SHP, NASDAQ: SHPG) presents scientific data comparing the efficacy and safety of the Attention Deficit/Hyperactivity Disorder (ADHD) treatments lisdexamfetamine dimesylate (LDX) and atomoxetine (ATX) at the 4th World Congress on ADHD, Milan, Italy. The study (SPD489-317) is the first head-to-head trial in children and adolescents with at least moderately symptomatic ADHD and an inadequate response to previous methylphenidate therapy... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 11, 2013 Category: Consumer Health News Tags: ADHD Source Type: news
Use Of Stimulant Medication In Childhood Not Associated With Increased Risk Of Substance Use Disorders In Adulthood, Study Suggests
The treatment of attention-deficit/hyperactivity disorder (ADHD) with stimulant medication is not associated with either an increased or decreased risk of later substance use disorders, according to a meta-analysis published Online First by JAMA Psychiatry, a JAMA Network publication. The use of medication, most often with stimulant medication (e.g., methylphenidate and mixed amphetamine salts), is a well-established treatment for ADHD and constitutes the first-line ADHD treatment in many clinical settings... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 29, 2013 Category: Consumer Health News Tags: Alcohol / Addiction / Illegal Drugs Source Type: news
Brain Dopamine Transporter Levels Increased By Long-term ADHD Treatment
Long-term treatment of attention deficit/hyperactivity disorder (ADHD) with certain stimulant medications may alter the density of the dopamine transporter, according to research published in the open access journal PLOS ONE by Gene-Jack Wang and colleagues from Brookhaven National Laboratory and the intramural program at NIH. ADHD is commonly treated using drugs to target dysfunctional dopamine signaling in the brain, such as methylphenidate (commonly known as Ritalin)... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 17, 2013 Category: Consumer Health News Tags: ADHD Source Type: news
In Children With ADHD Methylphenidate 'Normalizes' Activation In Key Brain Areas
The stimulant drug methylphenidate "normalizes" activation of several brain areas in young patients with attention-deficit/hyperactivity disorder (ADHD), according to a review published in the May Harvard Review of Psychiatry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. Studies using functional magnetic resonance imaging (fMRI) show increased activation of key brain areas after a dose of methylphenidate in young patients with ADHD, according to the systematic review by Constance A... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 14, 2013 Category: Consumer Health News Tags: ADHD Source Type: news
Methylphenidate 'normalizes' activation in key brain areas in kids with ADHD
(Wolters Kluwer Health) The stimulant drug methylphenidate "normalizes" activation of several brain areas in young patients with attention-deficit/hyperactivity disorder, according to a review published in the May Harvard Review of Psychiatry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2013 Category: Global & Universal Source Type: news
Effect of single dose methylphenidate on walking and postural stability under single- and dual-task conditions in older adults--a double-blind randomized control trial - Shorer Z, Yaakov B, Guy T, Melzer I.
BACKGROUND: Methylphenidate (MPH) action may improve executive function and motor function. Effects of MPH on balance function in older adults were investigated. METHODS: A randomized controlled double-blind study examined the effects of a single dose of M... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - April 19, 2013 Category: Global & Universal Tags: Age: Elder Adults Source Type: news
ADHD Med May Boost Attention, Reduce Apathy in Alzheimer'sADHD Med May Boost Attention, Reduce Apathy in Alzheimer's
Methylphenidate can help improve attention and reduce apathy in Alzheimer's patients, new research shows. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 21, 2013 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Methylphenidate Didn't Ease Amphetamine DependenceMethylphenidate Didn't Ease Amphetamine Dependence
Extended-release methylphenidate was no better than placebo at reducing amphetamine or methamphetamine use in dependent individuals in a randomized double-blind trial. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 19, 2013 Category: Consumer Health News Tags: Psychiatry News Source Type: news
High Fat Diets Maybe Linked To ADHD And Learning Problems
Diets that are high in fat are possibly linked to childhood brain-based conditions, such as memory-dependent learning disabilities and attention-deficit hyperactivity disorder (ADHD), researchers from the University of Illinois College of Medicine reported in Psychoneuroendocrinology. Senior author, Gregory Freund, said: "We found that a high-fat diet rapidly affected dopamine metabolism in the brains of juvenile mice, triggering anxious behaviors and learning deficiencies. Interestingly, when methylphenidate (Ritalin) was administered, the learning and memory problems went away... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 23, 2013 Category: Consumer Health News Tags: Nutrition / Diet Source Type: news
Elvanse® (lisdexamfetamine dimesylate) receives UK marketing authorisation for the treatment of ADHD in children and adolescents
Source: Shire plc
Area: News
The MHRA has granted a marketing authorisation to Shire plc for Elvanse® (lisdexamfetamine dimesylate) for the treatment of attention deficit/hyperactivity disorder (ADHD) in children aged 6 years and over when response to previous methylphenidate treatment is considered clinically inadequate. Lisdexamfetamine is a once daily long-acting prodrug stimulant, which is due to be launched in the UK at the beginning March (further details on formulations, cost, dosing etc will not be available untill product launch). (Source: NeLM - Mental Health)
Source: NeLM - Mental Health - February 14, 2013 Category: Psychiatry Source Type: news
Elvanse® (Lisdexamfetamine Dimesylate) Receives UK Marketing Authorisation - New Option For The Treatment Of ADHD In Children And Adolescents
Shire plc (LSE: SHP, NASDAQ: SHPG) have announced that its single-daily dose long-acting prodrug stimulant, Elvanse, has been authorised by the MHRA for the treatment of ADHD in children aged 6 years and over when response to previous methylphenidate treatment is considered clinically inadequate.2 Elvanse is the first stimulant prodrug to be launched in Europe for the treatment of ADHD. It is ingested in an inactive form and subsequently activated within the body, meaning that the active part of Elvanse is gradually released over time... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 13, 2013 Category: Consumer Health News Tags: ADHD Source Type: news
